Traffic:
10E
10W
15N
15S
57N
57S
60E
60W
210E
210W
This Site
Web Search
powered by
YAHOO! SEARCH
Subscriber Services
|
Home Delivery
|
e-Edition
|
Alerts
|
RSS
Home
News
Ontario
Rancho Cucamonga
Pomona
Upland
Claremont
Montclair
Chino Valley
California
Crime & Public Safety
Elections
Education
S.B. County Watch
Upland Watch
I.E.: Medicare Testing Ground
Sports
Buy Event Tickets Now
Golf - Tee Times and Courses
Preps
Reign Hockey
Rancho Cucamonga Quakes
Local Colleges
USC
UCLA
Lakers
Clippers
Dodgers
Angels
Ducks
Soccer
Motor Sports
Horse Racing
Live Odds
Business
Autos
Real Estate News
Technology
Opinions
Editorial
Letters
Columnists
Blogs
LA.COM
Buy Tickets
Movies
TV
Music
Shopping & Beauty
Recreation
Neighborhood
Arts
Living
Dining
Find A Restaurant
Lottery
Horoscopes
Travel
Trevor's Travels
Health
Crossword Puzzle
Local Casinos
Foothills Magazine
Info
Subscribe For Home Delivery
Contact Us
RSS
Podcast
Subscriber Services
Place An Ad
NIE
Classified
Place an Ad
Homes
Jobs
Auto
Search autos
Buy/Sell a car
Research/Financing a car
Find a dealer
Shopping
This week's ads
Obits
Directories
Local Business
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Articles published by Cara Therapeutics, Inc.
Cara Therapeutics Announces Exploration of Strategic Alternatives
July 11, 2024
From
Cara Therapeutics, Inc.
Via
GlobeNewswire
Tickers
CARA
Cara Therapeutics Announces Outcome of Part A of KOURAGE-1 Study Evaluating Oral Difelikefalin in Notalgia Paresthetica
June 12, 2024
From
Cara Therapeutics, Inc.
Via
GlobeNewswire
Tickers
CARA
Cara Therapeutics Reports First Quarter 2024 Financial Results
May 13, 2024
From
Cara Therapeutics, Inc.
Via
GlobeNewswire
Tickers
CARA
Cara Therapeutics to Announce First Quarter 2024 Financial Results on May 13, 2024
May 06, 2024
From
Cara Therapeutics, Inc.
Via
GlobeNewswire
Tickers
CARA
Cara Therapeutics to Present at the 23rd Annual Needham Virtual Healthcare Conference
April 02, 2024
From
Cara Therapeutics, Inc.
Via
GlobeNewswire
Tickers
CARA
Cara Therapeutics to Host Notalgia Paresthetica (NP) Virtual KOL Event on Wednesday, March 27, 2024
March 07, 2024
From
Cara Therapeutics, Inc.
Via
GlobeNewswire
Tickers
CARA
Cara Therapeutics Announces Fourth Quarter and Full Year 2023 Financial Results
March 04, 2024
From
Cara Therapeutics, Inc.
Via
GlobeNewswire
Tickers
CARA
Cara Therapeutics to Announce Fourth Quarter and Full Year 2023 Financial Results on March 4, 2024
February 12, 2024
From
Cara Therapeutics, Inc.
Via
GlobeNewswire
Tickers
CARA
Cara Therapeutics Prioritizes Late-Stage Notalgia Paresthetica Program and Extends Cash Runway into 2026
January 22, 2024
From
Cara Therapeutics, Inc.
Via
GlobeNewswire
Tickers
CARA
Cara Therapeutics Announces Outcome from Dose-Finding Part A of KIND 1 Study Evaluating Oral Difelikefalin for Moderate-to-Severe Pruritus in Patients with Atopic Dermatitis
December 18, 2023
From
Cara Therapeutics, Inc.
Via
GlobeNewswire
Tickers
CARA
Cara Therapeutics Reports Third Quarter 2023 Financial Results
November 13, 2023
From
Cara Therapeutics, Inc.
Via
GlobeNewswire
Tickers
CARA
Cara Therapeutics Announces up to $40.0 Million Non-Dilutive Financing Agreement with HealthCare Royalty
November 02, 2023
From
Cara Therapeutics, Inc.
Via
GlobeNewswire
Tickers
CARA
Cara Therapeutics to Announce Third Quarter 2023 Financial Results on November 13, 2023
October 23, 2023
From
Cara Therapeutics, Inc.
Via
GlobeNewswire
Tickers
CARA
Cara Therapeutics Announces Approval of KORSUVA® IV Injection Syringe in Japan for the Treatment of Pruritus in Hemodialysis Patients
September 25, 2023
From
Cara Therapeutics, Inc.
Via
GlobeNewswire
Tickers
CARA
Cara Therapeutics to Present at the H.C. Wainwright 25th Annual Global Investment Conference
September 05, 2023
From
Cara Therapeutics, Inc.
Via
GlobeNewswire
Tickers
CARA
Cara Therapeutics Reports Second Quarter 2023 Financial Results
August 07, 2023
From
Cara Therapeutics, Inc.
Via
GlobeNewswire
Tickers
CARA
Cara Therapeutics Appoints Helen M. Boudreau to Board of Directors
August 03, 2023
From
Cara Therapeutics, Inc.
Via
GlobeNewswire
Tickers
CARA
Cara Therapeutics to Present at the Canaccord Genuity 43rd Annual Growth Conference
August 02, 2023
From
Cara Therapeutics, Inc.
Via
GlobeNewswire
Tickers
CARA
Cara Therapeutics to Announce Second Quarter 2023 Financial Results on August 7, 2023
July 24, 2023
From
Cara Therapeutics, Inc.
Via
GlobeNewswire
Tickers
CARA
Cara Therapeutics to Present at the Jefferies Healthcare Conference
June 01, 2023
From
Cara Therapeutics, Inc.
Via
GlobeNewswire
Tickers
CARA
Kapruvia® (difelikefalin) recommended by England’s NICE for the treatment of adults with moderate-to-severe CKD-associated pruritus
May 18, 2023
From
Cara Therapeutics, Inc.
Via
GlobeNewswire
Tickers
ASX:CSL
CARA
CSLLY
Cara Therapeutics Reports First Quarter 2023 Financial Results
May 15, 2023
From
Cara Therapeutics, Inc.
Via
GlobeNewswire
Tickers
CARA
Cara Therapeutics to Announce First Quarter 2023 Financial Results on May 15, 2023
May 01, 2023
From
Cara Therapeutics, Inc.
Via
GlobeNewswire
Tickers
CARA
Cara Therapeutics Announces Presentation at the 22nd Annual Needham Virtual Healthcare Conference
April 10, 2023
From
Cara Therapeutics, Inc.
Via
GlobeNewswire
Tickers
CARA
Cara Therapeutics Releases Inaugural Environmental, Social, and Governance Report
March 14, 2023
From
Cara Therapeutics, Inc.
Via
GlobeNewswire
Tickers
CARA
Cara Therapeutics Announces Fourth Quarter and Full Year 2022 Financial Results
March 06, 2023
From
Cara Therapeutics, Inc.
Via
GlobeNewswire
Tickers
CARA
Cara Therapeutics to Announce Fourth Quarter and Full Year 2022 Financial Results on March 6, 2023
February 21, 2023
From
Cara Therapeutics, Inc.
Via
GlobeNewswire
Tickers
CARA
Cara Therapeutics Announces Results from the KOMFORT Phase 2 Trial of Oral Difelikefalin for the Treatment of Pruritus in Notalgia Paresthetica Published in the New England Journal of Medicine
February 08, 2023
From
Cara Therapeutics, Inc.
Via
GlobeNewswire
Tickers
CARA
Cara Therapeutics to Host Capital Markets Day on Thursday, February 16, 2023
January 17, 2023
From
Cara Therapeutics, Inc.
Via
GlobeNewswire
Tickers
CARA
Cara Therapeutics Announces Presentation at the 41st Annual J.P. Morgan Healthcare Conference
January 03, 2023
From
Cara Therapeutics, Inc.
Via
GlobeNewswire
Tickers
CARA
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.
Privacy Policy
|
Terms of Use
|
MNG Corporate Site Map
|
Copyright